Quartz·1 min read·easy
Amgen is raising its outlook after beating earnings and dropping a weight loss drug
✦AI Summary
Biotech firm Amgen has raised its full-year revenue forecast to a range of $38.2 billion to $39.4 billion. This follows a strong second quarter where the company saw a 10% increase in revenue to $10.1 billion.
The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in